down arrow

Neuland Labs.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE794A01010
  • NSEID: NEULANDLAB
  • BSEID: 524558
INR
11,690.80
790.75 (7.25%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 41.64 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

11,212.4011,813.75

52 Week

5,557.0018,089.55
Valuation
Technical
Day's Volume

CASH

41.64 k (-12.09%) Volume

Shareholding (Dec 2024)

FII

23.86%

Held by 198 FIIs

DII

9.48%

Held by 8 DIIs

Promoter

32.68%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Negative results in Dec 24

  • PBT LESS OI(Q) At Rs 68.07 cr has Fallen at -19.6 %
  • PAT(Q) At Rs 57.24 cr has Fallen at -13.3 %
2

Stock is technically in a Bearish range

3

With ROE of 18.9, it has a Very Expensive valuation with a 10 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 14,999 Cr (Mid Cap)

stock-summary
P/E

58.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.13%

stock-summary
Debt Equity

-0.06

stock-summary
Return on Equity

18.93%

stock-summary
Price to Book

10.02

Revenue and Profits (1 Year):
Net Sales:
398 Cr
(Quarterly Results - Dec 2024)
Net Profit:
102 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.13%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-18.06%
0%
-18.06%
1 Year
89.19%
0.18%
89.37%
2 Years
459.13%
1.11%
460.24%
3 Years
715.68%
2.79%
718.47%
4 Years
389.49%
1.59%
391.08%
5 Years
3275.92%
7.75%
3283.67%

Latest dividend: 14 per share ex-dividend date: Jul-12-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
15.57%
EBIT Growth (5y)
39.39%
EBIT to Interest (avg)
16.85
Debt to EBITDA (avg)
1.11
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.97
Tax Ratio
24.89%
Dividend Payout Ratio
6.02%
Pledged Shares
0
Institutional Holding
33.34%
ROCE (avg)
17.05%
ROE (avg)
13.21%
Valuation key factors
Factor
Value
P/E Ratio
58
Industry P/E
33
Price to Book Value
10.02
EV to EBIT
44.28
EV to EBITDA
36.68
EV to Capital Employed
10.58
EV to Sales
9.07
PEG Ratio
NA
Dividend Yield
0.13%
ROCE (Latest)
26.61%
ROE (Latest)
18.93%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 16 Schemes (6.29%)

FIIs

Held by 198 FIIs (23.86%)

Promoter with highest holding

Ramamohan Rao Davuluri (21.63%)

Highest Public shareholder

Malabar India Fund Limited (5.76%)

Individual Investors Holdings

26.05%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 28.05% vs -29.29% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 209.35% vs -66.45% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "398.03",
          "val2": "310.84",
          "chgp": "28.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "86.60",
          "val2": "62.22",
          "chgp": "39.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.22",
          "val2": "1.06",
          "chgp": "109.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "55.78",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "101.59",
          "val2": "32.84",
          "chgp": "209.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.76%",
          "val2": "20.02%",
          "chgp": "1.74%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -3.88% vs 51.64% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -13.50% vs 212.06% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "750.45",
          "val2": "780.74",
          "chgp": "-3.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "185.59",
          "val2": "234.40",
          "chgp": "-20.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.73",
          "val2": "6.65",
          "chgp": "-43.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "20.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "130.72",
          "val2": "151.13",
          "chgp": "-13.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.73%",
          "val2": "30.02%",
          "chgp": "-5.29%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -2.14% vs 49.67% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -0.09% vs 194.40% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,148.48",
          "val2": "1,173.57",
          "chgp": "-2.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "272.19",
          "val2": "355.66",
          "chgp": "-23.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.95",
          "val2": "10.39",
          "chgp": "-42.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "76.41",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "232.31",
          "val2": "232.52",
          "chgp": "-0.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.70%",
          "val2": "30.31%",
          "chgp": "-6.61%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 30.84% vs 25.25% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 83.51% vs 156.22% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,558.58",
          "val2": "1,191.20",
          "chgp": "30.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "462.59",
          "val2": "271.85",
          "chgp": "70.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.00",
          "val2": "13.07",
          "chgp": "7.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "300.08",
          "val2": "163.52",
          "chgp": "83.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.68%",
          "val2": "22.82%",
          "chgp": "6.86%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
398.03
310.84
28.05%
Operating Profit (PBDIT) excl Other Income
86.60
62.22
39.18%
Interest
2.22
1.06
109.43%
Exceptional Items
55.78
0.00
Consolidate Net Profit
101.59
32.84
209.35%
Operating Profit Margin (Excl OI)
21.76%
20.02%
1.74%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 28.05% vs -29.29% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 209.35% vs -66.45% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
750.45
780.74
-3.88%
Operating Profit (PBDIT) excl Other Income
185.59
234.40
-20.82%
Interest
3.73
6.65
-43.91%
Exceptional Items
20.63
0.00
Consolidate Net Profit
130.72
151.13
-13.50%
Operating Profit Margin (Excl OI)
24.73%
30.02%
-5.29%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -3.88% vs 51.64% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -13.50% vs 212.06% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,148.48
1,173.57
-2.14%
Operating Profit (PBDIT) excl Other Income
272.19
355.66
-23.47%
Interest
5.95
10.39
-42.73%
Exceptional Items
76.41
0.00
Consolidate Net Profit
232.31
232.52
-0.09%
Operating Profit Margin (Excl OI)
23.70%
30.31%
-6.61%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -2.14% vs 49.67% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -0.09% vs 194.40% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,558.58
1,191.20
30.84%
Operating Profit (PBDIT) excl Other Income
462.59
271.85
70.16%
Interest
14.00
13.07
7.12%
Exceptional Items
0.00
0.00
Consolidate Net Profit
300.08
163.52
83.51%
Operating Profit Margin (Excl OI)
29.68%
22.82%
6.86%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 30.84% vs 25.25% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 83.51% vs 156.22% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Neuland Laboratories Ltd stock-summary
stock-summary
Neuland Laboratories Ltd
Mid Cap
Pharmaceuticals & Drugs
Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao. The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin. Neuland Drugs & Pharmaceuticals Pvt. Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992. NLL manufactures bulk drugs.
Company Coordinates stock-summary
Company Details
11 Th Floor Phoenix IVY Buildi, Plot No 573A-III Road No 82 Hyderabad Telangana : 500035
stock-summary
Tel: 91-40-30211600
stock-summary
http://www.neulandlabs.com
stock-summary
ir@neulandlabs.com
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."